6,779 reports of this reaction
2.7% of all CARVEDILOL reports
#4 most reported adverse reaction
DIZZINESS is the #4 most commonly reported adverse reaction for CARVEDILOL, manufactured by Waylis Therapeutics LLC. There are 6,779 FDA adverse event reports linking CARVEDILOL to DIZZINESS. This represents approximately 2.7% of all 250,588 adverse event reports for this drug.
Patients taking CARVEDILOL who experience dizziness should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIZZINESS is a less commonly reported adverse event for CARVEDILOL, but still significant enough to appear in the safety profile.
In addition to dizziness, the following adverse reactions have been reported for CARVEDILOL:
The following drugs have also been linked to dizziness in FDA adverse event reports:
DIZZINESS has been reported as an adverse event in 6,779 FDA reports for CARVEDILOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIZZINESS accounts for approximately 2.7% of all adverse event reports for CARVEDILOL, making it a notable side effect.
If you experience dizziness while taking CARVEDILOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.